期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 89, 期 3, 页码 464-467出版社
WILEY
DOI: 10.1038/clpt.2010.279
关键词
-
资金
- National Institutes of Health's (National Institute of General Medical Sciences, National Institute of Child Health and Human Development, and National Cancer Institute) Pharmacogenomics Research Network (PGRN) [PAAR4Kids (UO1 GM92666), P30 CA21765, PharmGKB (R24 GM61374)]
- ALSAC
The slow rate at which pharmacogenetic tests are being adopted in clinical practice is partly due to the lack of specific guidelines on how to adjust medications on the basis of the genetic test results. One of the goals of the Clinical Pharmacogenetics Implementation Consortium (CPIC) of the National Institutes of Health's Pharmacogenomics Research Network (http://www.pgrn.org) and the Pharmacogenomics Knowledge Base (PharmGKB, http://www.pharmgkb.org) is to provide peer-reviewed, updated, evidence-based, freely accessible guidelines for gene/drug pairs. These guidelines will facilitate the translation of pharmacogenomic knowledge from bench to bedside.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据